Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEVEN R GOLDSTEIN

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1558362210
CMS profile
251683
Location
NEW YORK, NY

General Payments · PY2018–2024

$685,027.10

  • Reported across 319 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$64,670.71

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Astellas Pharma Europe Ltd $38,338.79 22
PFIZER INC. $11,737.55 8
Astellas Pharma US Inc $8,447.27 7
Novo Nordisk AS $4,907.15 5
Astellas Pharma Inc $588.79 4
Afaxys, Inc. $337.50 1
Bayer HealthCare Pharmaceuticals Inc. $265.29 3
Grifols USA, LLC $48.37 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $176,759.44 77
PY2019 $128,449.01 81
PY2020 $44,960.25 17
PY2021 $11,107.38 9
PY2022 $73,327.81 27
PY2023 $185,752.50 55
PY2024 $64,670.71 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Afaxys, Inc. $337.50 05/09/2024 Consulting Fee Undisputed 01/23/2026 1146429907 CMS
Astellas Pharma Europe Ltd $2,902.08 01/10/2024 Travel and Lodging Undisputed 01/23/2026 1121141189 CMS
Astellas Pharma Europe Ltd $8.28 01/12/2024 Food and Beverage Undisputed 01/23/2026 1121140885 CMS
Astellas Pharma Europe Ltd $17.66 01/12/2024 Food and Beverage Undisputed 01/23/2026 1121140889 CMS
Astellas Pharma Europe Ltd $6.62 01/12/2024 Food and Beverage Undisputed 01/23/2026 1121140891 CMS
Astellas Pharma Europe Ltd $43.04 01/12/2024 Food and Beverage Undisputed 01/23/2026 1121140893 CMS
Astellas Pharma Europe Ltd $66.22 01/12/2024 Food and Beverage Undisputed 01/23/2026 1121141037 CMS
Astellas Pharma Europe Ltd $31.19 01/12/2024 Travel and Lodging Undisputed 01/23/2026 1121141191 CMS
Astellas Pharma Europe Ltd $16.55 01/13/2024 Food and Beverage Undisputed 01/23/2026 1121140883 CMS
Astellas Pharma Europe Ltd $7.17 01/13/2024 Food and Beverage Undisputed 01/23/2026 1121140919 CMS
Astellas Pharma Europe Ltd $40.83 01/13/2024 Food and Beverage Undisputed 01/23/2026 1121140973 CMS
Astellas Pharma Europe Ltd $8.28 01/13/2024 Food and Beverage Undisputed 01/23/2026 1121141067 CMS
Astellas Pharma Europe Ltd $86.08 01/14/2024 Food and Beverage Undisputed 01/23/2026 1121140887 CMS
Astellas Pharma Europe Ltd $659.95 01/14/2024 Travel and Lodging Undisputed 01/23/2026 1121141195 CMS
Astellas Pharma Europe Ltd $10,400.00 02/12/2024 Consulting Fee Undisputed 01/23/2026 1121141087 CMS
Astellas Pharma Europe Ltd $405.18 02/12/2024 Travel and Lodging Undisputed 01/23/2026 1121141207 CMS
Astellas Pharma Europe Ltd $340.78 06/10/2024 Consulting Fee Undisputed 01/23/2026 1121140987 CMS
Astellas Pharma Europe Ltd $5,100.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 1121141025 CMS
Astellas Pharma Europe Ltd $1,950.00 08/05/2024 Consulting Fee Undisputed 01/23/2026 1121140895 CMS
Astellas Pharma Europe Ltd $1,300.00 11/18/2024 Consulting Fee Undisputed 01/23/2026 1121140945 CMS
Astellas Pharma Europe Ltd $4,760.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 1121141081 CMS
Astellas Pharma Europe Ltd $9,957.51 12/09/2024 Travel and Lodging Undisputed 01/23/2026 1121141111 CMS
Astellas Pharma Europe Ltd $231.37 12/09/2024 Travel and Lodging Undisputed 01/23/2026 1121141199 CMS
Astellas Pharma Inc $10.90 10/18/2024 Food and Beverage Undisputed 01/23/2026 1128595548 CMS
Astellas Pharma Inc $180.75 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1128595584 CMS
Astellas Pharma Inc $216.39 10/18/2024 Travel and Lodging Undisputed 01/23/2026 1128595586 CMS
Astellas Pharma Inc $180.75 10/23/2024 Travel and Lodging Undisputed 01/23/2026 1128595582 CMS
Astellas Pharma US Inc $125.00 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139378172 CMS
Astellas Pharma US Inc $1,950.00 01/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139386436 CMS
Astellas Pharma US Inc $54.88 04/13/2024 Food and Beverage Undisputed 01/23/2026 1139378174 CMS
Astellas Pharma US Inc $1,950.00 04/13/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139386434 CMS
Astellas Pharma US Inc $142.39 09/12/2024 Food and Beverage Undisputed 01/23/2026 1139408011 CMS
Astellas Pharma US Inc $650.00 10/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1139438044 CMS
Astellas Pharma US Inc $3,575.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1139447960 CMS
Bayer Healthcare Pharmaceuticals Inc. $120.28 07/24/2024 Food and Beverage Undisputed 01/23/2026 1086175914 CMS
Bayer Healthcare Pharmaceuticals Inc. $100.06 09/12/2024 Food and Beverage Undisputed 01/23/2026 1086137647 CMS
Bayer Healthcare Pharmaceuticals Inc. $44.95 09/12/2024 Food and Beverage Undisputed 01/23/2026 1086255114 CMS
Grifols USA, LLC $16.09 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124741130 CMS
Grifols USA, LLC $15.19 06/04/2024 Food and Beverage Undisputed 01/23/2026 1124741128 CMS
Grifols USA, LLC $17.09 11/12/2024 Food and Beverage Undisputed 01/23/2026 1124741126 CMS
Novo Nordisk Inc $518.00 05/31/2024 Consulting Fee Undisputed 01/23/2026 1097494128 CMS
Novo Nordisk Inc $4,144.00 06/03/2024 Consulting Fee Undisputed 01/23/2026 1097498076 CMS
Novo Nordisk Inc $30.00 09/06/2024 Food and Beverage Undisputed 01/23/2026 1096777314 CMS
Novo Nordisk Inc $162.37 09/10/2024 Food and Beverage Undisputed 01/23/2026 1097800495 CMS
Novo Nordisk Inc $52.78 09/12/2024 Food and Beverage Undisputed 01/23/2026 1097284253 CMS
PFIZER INC. $351.92 07/26/2024 Travel and Lodging Undisputed 01/23/2026 1131639799 CMS
PFIZER INC. $105.00 07/26/2024 Food and Beverage Undisputed 01/23/2026 1131639803 CMS
PFIZER INC. $5,850.00 08/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131908982 CMS
PFIZER INC. $1,300.00 10/08/2024 Consulting Fee Undisputed 01/23/2026 1131223758 CMS
PFIZER INC. $1,023.22 10/21/2024 Travel and Lodging Undisputed 01/23/2026 1131640513 CMS
PFIZER INC. $94.91 12/06/2024 Travel and Lodging Undisputed 01/23/2026 1131230095 CMS
PFIZER INC. $2,993.07 12/06/2024 Travel and Lodging Undisputed 01/23/2026 1131629485 CMS
PFIZER INC. $19.43 12/10/2024 Food and Beverage Undisputed 01/23/2026 1131639807 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.